Offenbach Am Main

Germany

42 total trials 17 recruiting

Filter these 42 trials by phase, condition, sponsor and more.

Open in Search →

Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic … Ended recruitment

2023-509825-38-00 5 2022-12-01 Metastatic Non–Small Cell Lung Cancer
AFAMOSI: Prospective, randomized, multicenter Phase IV study to evaluate the efficacy and safety of afatinib followed by osimertinib compare … Ended recruitment

2024-511625-55-00 6 2022-11-30 EGFRmutated/T790M Mutation negative non-squamous NSCLC
Phase 1 / 2 Study Evaluating MCLA-129 in Advanced NSCLC Ended recruitment

2024-514461-19-00 9 2021-09-09 Solid Tumors
Phase 3 Study of MRTX849 vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation Ended recruitment

2023-507263-19-00 5 2020-12-23 Advanced Non-Small Cell Lung Cancer
A study on the efficacy and safety of cisplatin/etoposide and concomitant radiotherapy in combination with durvalumab, an immunotherapy, in … Ended recruitment

2024-513433-20-00 4 2020-12-16 Limited Disease Small Cell Lung Cancer
Sacituzumab Govitecan in primary HER2-negative breast cancer (SASCIA) Ended recruitment

2023-510390-33-00 5 2020-10-23 HER2-negative breast cancer patients with high relapse risk after stan
Short course radiotherapy versus chemoradiotherapy, followed by consolidation chemotherapy, and selective organ preservation for MRI-defined … Ended recruitment

2024-511577-29-01 5 2020-03-13 intermediate and high-risk rectal cancer
Adjuvant Dynamic marker - Adjusted Personalized Therapy comparing endocrine therapy plus ribociclib versus chemotherapy in intermediate-risk … Ended recruitment

2024-515769-32-00 5 2019-07-02 HR+/HER2- early breast cancer
Phase III study of pembrolizumab for high-risk early-stage ER+/HER2– breast cancer Ended recruitment

2023-506921-12-00 5 2018-12-27 ER+/HER2- Breast Cancer
Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer (monarchE) Ended recruitment

2023-509671-17-00 5 2017-07-12 Breast Cancer
Olaparib as adjuvant treatment in patients with germline BRCA mutated high risk HER2negative primary breast cancer. Ended recruitment

2024-511096-15-00 5 2014-08-01 Breast Cancer
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy Ended

2024-513435-24-01 4 2025-06-03 Neuropathic Pain; Distal Sensory Polyneuropathy
A Study to Investigate the Safety, Efficacy, and Immunogenicity of mRNA-1010 Candidate Influenza Vaccine Compared with a Licensed Influenza … Ended

2024-516240-26-00 5 2024-10-11 Influenza
A randomized, multicenter, open-label trial comparing the effectiveness of Inclisiran to bempedoic acid on LDL cholesterol (LDL-C) lowering … Ended

2024-511076-32-00 6 2024-06-21 Hypercholesterolemia
Thoracic Radiotherapy plus Durvalumab in Elderly and/or frail NSCLC stage III patients unfit for chemotherapy - Employing optimized (hypofra … Ended

2024-513948-28-00 4 2020-05-08 unresectable stage III NSCLC (Non–small-cell lung cancer)
This is a phase III randomised, double-blind, placebo-controlled, multicentre, global study to assess the effectiveness and safety of standa … Ended

2022-502747-35-00 5 2019-02-18 Newly diagnosed advanced (FIGO stage III-IV) high grade epithelial ova
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy with Atezolizumab or Placebo in Patients with Triple-Negati … Ended

2023-508472-11-00 5 2018-06-13 Patients with early breast cancer
CHRONOS - A study to learn about the effects and safety of ODM-111 in participants with long-lasting pain due to osteoarthritis of the knee. Ended

2024-513553-79-00 4 Chronic Pain due to Ostheoarthritis of the knee

Showing 25–42 of 42 trials